ESO and ALPAO sign 2 major contracts to develop new deformable mirrors for next generation instruments

The European Southern Observatory and the French company ALPAO will join efforts to develop the future of adaptive optics for extremely large telescopes. ESO and ALPAO announced the signing of 2 contracts for a Compact and an Extreme Adaptive…

Inauguration ceremony at the new US site

On Friday, April 22, 2016, RAUMEDIC inaugurated its new US headquarters in Mills River. The new high-tech development and production center is an important investment in RAUMEDIC’s future. Following the demand of their customers for a local…

French Research Team Helps Extend MRI Detection of Diseases & Lower Health-Care Costs

CEA, INSERM and G2ELab Brings Grenoble Region’s Expertise In Advanced Medicine & Magnetism Applications to H2020 IDentIFY Project Three Grenoble-based research and medical partners have been selected to join the European Union-funded…

Appointment of Sandra Cortès as Chief Scientific Officer of SYNTHELIS

Since 2012, Sandra Cortès has played a major role in the scientific activities of SYNTHELIS. The high level of her scientific skills, her commitment as well as her managerial competency led her naturally to a position at the height of her professional…

ENTEGRIS developed a concentration monitor

ENTEGRIS developed the Invue concentration monitor to measure the concentration of solutions in-line and of-line during process at the downstream level. The article, to download below, highlights the index of refraction refraction as methodology…

SYNAPCELL’s article about the MTLE model published

We are delighted to share with you the publication of our article about the MTLE mouse: a model of focal epilepsy in CNS Neuroscience and Therapeutics. Our work is entitled "Differential effects of antiepileptic drugs on focal seizures in the…

RAUMEDIC at PHARMAPACK 2016

RAUMEDIC presents its newest developments in the field of injection, drug delivery and inhalation at Pharmapack 2016. On February 10 and 11 RAUMEDIC presents its newest technologies for the pharmaceutical industry on booth 407 at the Pharmapack…

ORTHOTAXY will participate to Medi’Nov Connection 2016

ORTHOTAXY will participate soon to a major event of the medical field: Medi’Nov Connection 2016. Medi’Nov Connection 2016 Medi’Nov Connection 2016 will be held on 16 & 17 March 2016 at the Congress Center of the World Trade Center…

AVALUN turns 2 !

Created in December 2013, the company Avalun has now turned two. Its innovative IVD device, the LabPad®, will be launched in 2016.

Initiated by AVALUN, the CORINNE project selected by the regional health agency (ARS)

Initiated by Avalun, this project aims at experiencing the INR measurement connected to biology laboratories for patients in nursing homes. Part of the National program implemented by the Ministry of Health for fostering eHealth, this living…